Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B5HF
|
||||
Former ID |
DNCL002837
|
||||
Drug Name |
BI-135585
|
||||
Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Phase 1 | [523331] | ||
Company |
Boehringer Ingelheim Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | Corticosteroid 11-beta-dehydrogenase, isozyme 1 | Target Info | Modulator | [551800] | |
NetPath Pathway | IL1 Signaling Pathway | ||||
FSH Signaling Pathway | |||||
PathWhiz Pathway | Steroidogenesis | ||||
Reactome | Glucocorticoid biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.